Work

LMP2-Cytotoxic T Lymphocyte Therapy for Relapsed EBV Positive Lymphoma.

Year: 2004

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v104.11.3276.3276

Authors: Catherine M. Bollard, Helen M. Huls, Karin C. Straathof, Stephen M. Gottschalk, Teresita Lopez, Chung-Che Chang, Mary V. Gresik, George Carrum, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop

Institution: Baylor College of Medicine

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979414952

FWCI:

Cites:

Cited by: 1

Related to: 10